Find the latest pharmaceutical market place for formulations enquiry about Pembrolizumab on PharmaCompass.com.

Tender// Pembrolizumab (25 mg/ ml in 4 ml) Injections needed in Bulgaria [ENA17853]

Universitetska Mnogoprofilna Bolnitsa Za Aktivno Lechenie Tsaritsa Yoanna-Isul Ead is looking for supplies of ?embrolizumab (25 mg/ ml in 4 ml) Injections for commercial purposes. The required quantity is 3,510 units. The deadline is 13-Sept-2023.

Reply

22 Aug 2023

Various Finished Dosage Formulations needed in Brazil [ENA16235]

A company that deals in the research, development & trading of health products is looking for suppliers of Various Finished Dosage Formulations for commercial purposes. The suppliers must support this enquiry with CTD Dossier.
1. Pembrolizumab (100 mg) Injections
2. Paclitaxel (6 mg, 30 mg, 100 mg, 150 mg & 300 mg) Injections
3. Nivolumab (40 mg & 100 mg) Injections
4. Oxaliplatin (5 mg, 50 mg & 100 mg) Injections
5. Bevacizumab (25 mg) Injections

Reply

28 Jan 2023

Tender// Various Finished Dosage Formulations needed in Poland [ENA16189]

Swietokrzyskie Centrum Onkologii Independent Public Health Care Center is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 21-Feb-2023.
1. Pembrolizumab (100 mg/ 4 ml) Solution for Infusions. The required quantity is 2,200 units.
2. Zoledronic Acid (4 mg/ 5 ml) Concentrate for Solution for Infusions. The required quantity is 900 units.

Reply

24 Jan 2023

Tender// Various Finished Dosage Formulations needed in Poland [ENA09429]

Wielkopolskie Center of Pulmonology and Thoracic Surgery Eugenia and Janusz Zeyland SP ZOZ is looking for suppliers of Various Finished Dosage Formulations. The deadline is 19-Jan-2021.
1. Teicoplanin (200 mg & 400 mg) Solution for Injection. The required quantity is 10 units for each.
2. Pembrolizumab (100 mg/ 4 ml) Solution for Injection. The required quantity is 230 units.
3. Atezolizumab (1200 mg/ 20 ml) Solution for Injection. The required quantity is 110 units.
4. Nintedanib (100 mg & 150 mg) Capsules. The required quantity is 15 units and 60 units respectively.
5. Mepolizumab (100 mg) Pen. The required is 30 units.
6. Mepolizumab (100 mg) Syringe. The required quantity is 10 units.
7. Amiodarone HCl (150 mg/ 3 ml) Ampoule in the packaging of 6 ampoules. The required quantity is 40 units.
8. Drotaverine HCl (40 mg/ 2 ml) Ampoule in the packaging of 5 ampoules. The required quantity is 40 units.
9. Tranexamic acid (500 mg/ 5 ml) Ampoule in the packaging of 5 ampoules. The required quantity is 150 units.
10. Rasburicase (1.5 mg) Vials in the packaging of 3 vials. The required quantity is 1 unit.
11. Enoxaparin Sodium (100 mg/ 1 ml, 20 mg/ 0.2 ml, 40 mg/ 0.4 ml, 60 mg/ 0.6 ml & 80 mg/ 0.8 ml). The required quantity is 60 units, 20 units, 900 units, 250 units and 200 units respectively.

Reply

07 Jan 2021

Tender// Various Finished Dosage Formulations needed in Estonia [ENA09367]

Sihtasutus Tartu Ülikooli Kliinikum is looking for supplies of Various Finished Dosage Formulations. The suppliers must support this tender with ESPD. The deadline is 25-Jan-2021.
1. Pertuzumab (420 mg) Concentration for Infusion. The required quantity is 450 units.
2. Pembrolizumab (100 mg) Powder for solution for Injection. The required quantity is 2,000 units.
3. Nivolumab (240 mg/ 24 ml) Concentration for Infusion. The required quantity is 480 units.
4. Obinutuzumb (1000 mg) Concentration for Infusion. The required quantity is 100 units.
5. Siponimodum (2 mg) Tablets. The required quantity is 1,000 units.
6. Upadacitinib (15 mg) Tablets. The required quantity is 2,000 units.

Reply

29 Dec 2020

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.